Nuveen Asset Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,974
| Closed | -$665K | – | 3331 |
|
|
2023
Q3 | $665K | Sell |
13,974
-73
| -0.5% | -$3.48K | ﹤0.01% | 2741 |
|
|
2023
Q2 | $1.35M | Sell |
14,047
-4,438
| -24% | -$425K | ﹤0.01% | 2513 |
|
|
2023
Q1 | $2.1M | Buy |
18,485
+3,266
| +21% | +$371K | ﹤0.01% | 2311 |
|
|
2022
Q4 | $1.71M | Sell |
15,219
-8,017
| -35% | -$898K | ﹤0.01% | 2462 |
|
|
2022
Q3 | $2.98M | Buy |
23,236
+12,993
| +127% | +$1.67M | ﹤0.01% | 2179 |
|
|
2022
Q2 | $702K | Sell |
10,243
-2,452
| -19% | -$168K | ﹤0.01% | 2929 |
|
|
2022
Q1 | $1.85M | Buy |
12,695
+653
| +5% | +$95.1K | ﹤0.01% | 2537 |
|
|
2021
Q4 | $1.92M | Sell |
12,042
-13,284
| -52% | -$2.12M | ﹤0.01% | 2580 |
|
|
2021
Q3 | $3.61M | Buy |
25,326
+11,158
| +79% | +$1.59M | ﹤0.01% | 2382 |
|
|
2021
Q2 | $1.31M | Buy |
14,168
+3,093
| +28% | +$287K | ﹤0.01% | 2897 |
|
|
2021
Q1 | $1.03M | Sell |
11,075
-92
| -0.8% | -$8.54K | ﹤0.01% | 2874 |
|
|
2020
Q4 | $1.04M | Buy |
11,167
+198
| +2% | +$18.4K | ﹤0.01% | 2792 |
|
|
2020
Q3 | $1.02M | Sell |
10,969
-1,933
| -15% | -$179K | ﹤0.01% | 2681 |
|
|
2020
Q2 | $1.23M | Buy |
12,902
+1,268
| +11% | +$121K | ﹤0.01% | 2539 |
|
|
2020
Q1 | $831K | Sell |
11,634
-818
| -7% | -$58.4K | ﹤0.01% | 2590 |
|
|
2019
Q4 | $859K | Sell |
12,452
-5,416
| -30% | -$374K | ﹤0.01% | 2739 |
|
|
2019
Q3 | $1.43M | Buy |
17,868
+13,716
| +330% | +$1.1M | ﹤0.01% | 2544 |
|
|
2019
Q2 | $267K | Buy |
+4,152
| New | +$267K | ﹤0.01% | 3117 |
|